Krka's generic Viagra is recommended for EU marketing
This article was originally published in Scrip
Executive Summary
Krka's Vizarsin, a generic of Pfizer's erectile dysfunction product Viagra (sildenafil) has been recommended for a centralised EU marketing authorisation. The CHMP said Vizarsin's quality and its bioequivalence with the reference product had been demonstrated satisfactorily.